Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy
- 1 June 2004
- journal article
- Published by Elsevier in The Lancet
- Vol. 363 (9427), 2116-2121
- https://doi.org/10.1016/s0140-6736(04)16500-8
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Mortality Risk for Patients with Cytomegalovirus Retinitis and Acquired Immune Deficiency SyndromeClinical Infectious Diseases, 2003
- Is cytomegalovirus infection a co-factor in HIV-1 disease progression?Epidemiology and Infection, 2000
- Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients.Journal of Clinical Investigation, 1998
- Development of cytomegalovirus (CMV) disease may be predicted in HIV-infected patients by CMV polymerase chain reaction and the antigenemia testAIDS, 1997
- Utility of Urine and Leukocyte Cultures and Plasma DNA Polymerase Chain Reaction for Identification of AIDS Patients at Risk for Developing Human Cytomegalovirus DiseaseThe Journal of Infectious Diseases, 1997
- Persistent Cytomegalovirus Infection of Semen Increases Risk of AIDSThe Journal of Infectious Diseases, 1994
- PROVISION OF PROGNOSTIC INFORMATION IN IMMUNOCOMPROMISED PATIENTS BY ROUTINE APPLICATION OF THE POLYMERASE CHAIN REACTION FOR CYTOMEGALOVIRUSTransplantation, 1993
- A clinico-pathological audit of opportunistic viral infections in HIV-infected patientsAIDS, 1993
- Cytomegalovirus (CMV) infection, CD4+ lymphocyte counts and the development of AIDS in HIV-1-infected haemophiliac patientsClinical and Experimental Immunology, 1992
- Human immunodeficiency virus‐1 disease progression in hemophiliacsAmerican Journal of Hematology, 1990